|
|
Volumn 341, Issue 8856, 1993, Pages 1293-1298
|
|
Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
ESTROGEN RECEPTOR;
FLUOROURACIL;
METHOTREXATE;
PREDNISOLONE;
ADULT;
ALOPECIA;
ARTICLE;
BREAST CARCINOMA;
CLINICAL TRIAL;
CONJUNCTIVITIS;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MASTECTOMY;
NAUSEA;
ORAL DRUG ADMINISTRATION;
OVARIECTOMY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
UNITED KINGDOM;
VOMITING;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
FEMALE;
FLUOROURACIL;
HUMAN;
METHOTREXATE;
MIDDLE AGE;
OVARIECTOMY;
OVARY;
PREDNISOLONE;
RECEPTORS, ESTROGEN;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL RATE;
|
|
EID: 0027263487
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/0140-6736(93)90812-U Document Type: Article |
|
Times cited : (210)
|
|
References (16)
|
